Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Similar documents
Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile

DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile

Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile

DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile

The Walt Disney Company - Strategy, SWOT and Corporate Finance Report

Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report

McCain Foods Limited, Inc. - Strategic SWOT Analysis Review

Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Phone: +44 (0) or BioPortfolio Limited

Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Surgical Sutures Market By Product Type [Automated Suturing Devices (Disposable Automated Suturing Devices, And Re-Usable Automated Suturing

Compression Therapy - Medical Devices Pipeline Assessment, 2017

Critical Limb Ischemia - Pipeline Review, H1 2017

Generics Series: Authorized Generics Analysis Stemming the Generics Tide

Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update

Global Paper Stationery Market Research Report 2016

April By Type of Approach- Transfemoral and Transapical. By Region- North America, Europe, APAC and RoW

Global Absolute Pressure Transmitters Market Research Report 2016

Global DAW Software Market Research Report 2016

Venture Capital Report

Digital Health Funding and M&A

United States Sterilization Equipment Market Outlook to 2021

1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Neurostimulation Devices Market - An Overview 3.

Indoor Positioning and Navigation System Market Research Report- Forecast 2023

Healthcare and Life Sciences

Venture Capital Report

Global Sequins Apparels Market Research Report 2016

Santander has a leadership position in the international financial sector thanks to our highly skilled team of professionals. We want the best people

New York Bar admission (or eligibility to obtain admission promptly) is required.

Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo Dr. Axel Braun F. Hoffmann La Roche Ltd.

2013 Global venture capital confidence survey results. How confident are investors?

Dealdoc. Acquisition agreement for Gambro. Baxter International Gambro. Dec , Wildwood Ventures Ltd. All rights reserved.

SMES AND GLOBAL GROWTH: FINDING LOCAL PARTNERS

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)

Intellectual property governance and strategic value creation:

Purvi B. Maniar Member of the Firm

Pharma - Biotech Collaborations: Optimizing Success, Minimizing Risk and Maintaining Alignment

2014 Global venture capital confidence survey results

WOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview

Military Robotics - Emerging Trends and Future Outlook. Reference code: DF4580PR Published: July 2015 Single user price: US$1950

China Ophthalmic Hospital Industry Report, May 2013

EXAMINATION NUMBER ONLY.

Licensing League Tables 3Q14

Financing SMEs and Entrepreneurs 2012

Nasir, Dao PKM Abdul Partner PwC Legal (Vietnam) Co., Ltd

Report on Global Sneaker Market by Player, Region, Type, Application and Sales Channel.pdf

WIPO-WASME Program on Practical Intellectual Property Rights Issues for Entrepreneurs, Economists, Bankers, Lawyers and Accountants

Financing Sources, Sales Pitch to Investors BARCELONA Aitana Peire Venture Valuation

Global and China Industrial Robot Industry Report, Sep. 2013

EXECUTIVE SUMMARY. Investment Opportunity. Paradox Financial Solutions Inc.

VentureSource Europe -- 3Q 2014

Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships

Monitoring R&D resource flows: Global resources and challenges

How attractive is the BioRegion of Catalonia for foreign investment? Guy Nohra Co-Founder and Managing Director of Alta Partners

Cherry AB. Investing in a broad gaming portfolio. CEO Anders Holmgren GP Bullhound 6 December 2017

Case No COMP/M BANCO SANTANDER / ABBEY NATIONAL. REGULATION (EC) No 139/2004 MERGER PROCEDURE. Article 6(1)(b) NON-OPPOSITION Date: 15/09/2004

China Jewelry Industry Report, Mar. 2012

HBM Healthcare Investments Ltd Access to a Global and Diversified Private Equity Healthcare Portfolio

Venture Capital Report

State of Licensing 2011 Update

Global and China Industrial Robot Speed Reducer Industry Report, Jun. 2014

JOHN JACK R. TUPMAN, JR CURRICULUM VITAE

Robert A. Greising Partner

CANADIAN PRIVATE EQUITY BUYOUT REVIEW

VALUATION TRENDS 18.8

At the forefront of Abu Dhabi s economic diversification. August 2008

Advisors. Firm Overview

GLOBAL PRIVATE EQUITY Report Charts

Find and analyse the most relevant patents for your research

World Offshore Wind Market Forecast Prospects, Technologies, World Markets

Bayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division

Venture Capital Report

I Overview. II Hallmarks of Turnpoint Group. III Corporate Financial Services. IV Assignments. V Clients. VI Market Segments

UNITED INTERNET. Business Applications Strategic Partnership with Warburg Pincus. November 8, Investor Presentation November 8, 2016

PitchBook. Bet ter Data. Bet ter Decisions. 4Q 2012 Private Equity. Company Inventory. Report. Sponsored by:

Venture Capital Report

The role of Intellectual Property (IP) in R&D-based companies: Setting the context of the relative importance and Management of IP

Robert A. Greising Partner

Transcription:

Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0)1300 321501 or Email: reportstore@bioportfolio.com 2

Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Faes Farma SA (Faes Farma) develops, manufactures and commercializes pharmaceutical products and raw materials. The company offers prescription drugs, over-the-counter medications and skin-care treatment products. Faes Farma also provides the raw-materials for pharmaceutical companies. Its product portfolio consists of active pharmaceutical ingredients and finished drugs. The company s product portfolio includes Actimag, Bronquidiazina CR, Bilaxten, Colme, Claversal, Dolotren, Dynamogen, Dolotren gel, Ferroprotina, Hidroferol, Lipofen, Potenciator, Positon and others. The company operates in Spain and Portugal. It also exports its products to more than 60 countries in Europe, Asia, Latin America, Africa and the Middle East. Faes Farma is headquartered in Madrid, Spain. Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma etrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of 3

the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Additional Details Publisher : Global Data Reference : GDPH56507D Number of Pages : 33 Report Format : PDF Publisher Information : 4

5

Table Of Contents for Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Table of Contents Table of Contents 2List of Tables 3List of Figures 4Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5Faes Farma SA, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8Faes Farma SA, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9Faes Farma SA, Pharmaceuticals & Healthcare, Deal Details 11Partnerships 11Faes Farma to Form Joint Venture with Eddingpharm 11Faes Farma Enters into Co- Marketing Agreement with Laboratorios Ordesa 12Faes Farma Forms Joint Venture With Mexico's Lab 13Faes Farma Enters Into Co-Marketing Agreement With SLA Pharma For Topical Metronidazole 14Faes Farma Enters Into Co-Marketing Agreement With Cinfa 15Licensing Agreements 16Faes Farma Enters into Licensing Agreement with Aralez Pharma 16Faes Farma Enters into Licensing Agreement with Marathon Pharma 17Tribute Pharma Enters Into Licensing Agreement With Faes Farma For Bilastine 18FAES Farma Enters into License Agreement with Menarini For Bilastina 19Taiho Pharma Enters Into Licensing Agreement With Faes Farma For Bilastine 20Faes Farma And Invida Enter Into Licensing Agreement For Bilastine 22FAES Farma And Pfizer Expand Bilastine License Agreement To 21 New Markets In Latin America 23Laboratorios SALVAT Enters Into Licensing Agreement With FAES Farma 24FAES Farma Enters Into License Agreement With Kalbe Farma For Bilastina 25FAES Farma Enters Into Licensing Agreement With Novartis Farmaceutica For Hirobriz and Breezhaler 26Pierre Fabre Medicament Enters into Licensing Agreement with FAES Farma and Menarini for Bilastine 27Equity Offering 28Faes Farma to Raise USD0.53 Million in Offering of Shares 28FAES Farma Completes Rights Offering For US$2 Million 29Faes Farma SA - Key Competitors 30Key Employees 31Locations And Subsidiaries 32Head Office 32Other Locations & Subsidiaries 32Appendix 33Methodology 33About GlobalData 33Contact Us 33Disclaimer 33 6

List Of Tables in Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Tables Faes Farma SA, Pharmaceuticals & Healthcare, Key Facts, 2015 1 Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 Faes Farma SA, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6 Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 Faes Farma SA, Deals By Therapy Area, 2010 to YTD 2016 8 Faes Farma SA, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9 Faes Farma to Form Joint Venture with Eddingpharm 11 Faes Farma Enters into Co- Marketing Agreement with Laboratorios Ordesa 12 Faes Farma Forms Joint Venture With Mexico's Lab 13 Faes Farma Enters Into Co-Marketing Agreement With SLA Pharma For Topical Metronidazole 14 Faes Farma Enters Into Co-Marketing Agreement With Cinfa 15 Faes Farma Enters into Licensing Agreement with Aralez Pharma 16 Faes Farma Enters into Licensing Agreement with Marathon Pharma 17 Tribute Pharma Enters Into Licensing Agreement With Faes Farma For Bilastine 18 FAES Farma Enters into License Agreement with Menarini For Bilastina 19 Taiho Pharma Enters Into Licensing Agreement With Faes Farma For Bilastine 20 Faes Farma And Invida Enter Into Licensing Agreement For Bilastine 22 FAES Farma And Pfizer Expand Bilastine License Agreement To 21 New Markets In Latin America 23 Laboratorios SALVAT Enters Into Licensing Agreement With FAES Farma 24 FAES Farma Enters Into License Agreement With Kalbe Farma For Bilastina 25 FAES Farma Enters Into Licensing Agreement With Novartis Farmaceutica For Hirobriz and Breezhaler 26 Pierre Fabre Medicament Enters into Licensing Agreement with FAES Farma and Menarini for Bilastine 27 Faes Farma to Raise USD0.53 Million in Offering of Shares 28 FAES Farma Completes Rights Offering For US$2 Million 29 Faes Farma SA, Key Competitors 30 Faes Farma SA, Key Employees 31 Faes Farma SA, Subsidiaries 32 7

List Of Figures, Charts and Diagrams in Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Figures Faes Farma SA, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1 Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1 Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1 Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1 Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 Faes Farma SA, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6 Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8 8

How to Buy... Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and email it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0)1305 791844.We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Email: Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $250 Single User Price $500 Site License Price $750 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will email you the invoice with a payment link) Direct Wire Transfer (we will email you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0)1300 321501 We will be delighted to give you our personal attention. 9